CX3CR1 and neoplasm: For the small intestine tumor model, independently from the CX3CR1 status, APC+/min and WT mice were shaved and injected, 24 h before the acquisition, with 0.08 nmol/g of body weight of IntegriSense750 probe after 14 and 18 weeks of age.